DoW Tuberous Sclerosis Complex, Clinical Translational Research Award
This grant funds clinical translational research focused on Tuberous Sclerosis Complex.
About this program
The DoW Tuberous Sclerosis Complex Clinical Translational Research Award supports innovative research aimed at improving the understanding and treatment of Tuberous Sclerosis Complex (TSC). This grant is intended for researchers and institutions dedicated to advancing clinical knowledge and therapeutic strategies for TSC, a genetic disorder that causes benign tumors to grow in various organs. The funding will facilitate projects that translate scientific discoveries into practical applications that can enhance patient care and outcomes. Eligible applicants include academic institutions, nonprofit organizations, and other entities engaged in health-related research. The grant aims to foster collaboration among researchers, clinicians, and patient advocacy groups to ensure that research findings are effectively implemented in clinical settings. By providing financial support for promising research initiatives, this grant seeks to accelerate the development of new treatments and improve the quality of life for individuals affected by TSC.
Eligibility
Academic institutions, nonprofit organizations, and other entities engaged in health-related research.